Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Video Releases    |    Pricing & Distribution Plans    |    Today's News    |    News By Category    |    News By Date    |    Business Directory
All Press Releases for March 20, 2013 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version   



New Treatment Shows Promise in Treating Spinal Cord Injuries
Fortunately, research recently published in The Journal of Neuroscience indicates that a new medication may help patients regain some bodily functions lost to spinal cord injury. 
x-small text small text medium text large text


    March 20, 2013 /24-7PressRelease/ -- New Treatment Shows Promise in Treating Spinal Cord Injuries

Article provided by Kammholz Messina, LLP
Visit us at http://www.kammholzlaw.com/

According to statistics compiled by the Centers for Disease Control and Prevention (CDC), approximately 200,000 people are currently living with a spinal cord injury (SCI) in the United States. Each year, an additional 12,000 to 20,000 people are estimated to suffer an SCI. The estimated lifetime cost of a spinal cord injury is anywhere from $500,000 to $3million, depending on the severity of the injury.

A traumatic injury to a person's spinal cord can result in permanent neurologic impairments in any body system affected by the damaged nerves, as well as psychological side effects. Fortunately, research recently published in The Journal of Neuroscience indicates that a new medication may help patients regain some bodily functions lost to SCI.

Experimental Drug

Researchers at Ohio State University examined the effect of an experimental drug, called LM11A-31, on lab mice with spinal cord injuries. The drug works by blocking the release of a protein after SCI that destroys the nerve cells that surround and protect axons, the structures that help transmit motor impulses from the brain to the rest of the body. What makes LM11A-31 particularly promising is its ability to cross the blood-brain barrier, the natural mechanism that separates brain extracellular fluid from circulating blood. The blood-brain barrier acts to protect the brain from blood-borne contaminants, but it also hinders the efficacy of drugs meant to treat SCI.

According to the researchers leading the study, the drug helped mice regain some normal function after their initial injuries. The mice received the drug four hours after their initial injuries in the initial study. Future studies are expected to determine whether the drug is effective if administered weeks or months after the injury.

More research is needed to determine whether the drug would be as effective for human patients, but the authors of the study hope that the drug could be used in conjunction with current therapies to improve and restore some function.

A Personal Injury Attorney Can Help

If you or someone you love has suffered a spinal cord injury, traumatic brain injury or any other catastrophic injury due to the negligence of another person, contact an experienced personal injury attorney. A knowledgeable personal injury lawyer can assess your case and help you get the fair and adequate compensation you deserve for medical bills, lost wages and pain and suffering. For more information about how a personal injury lawyer can help you, contact an attorney today.


---
Press release service and press release distribution provided by http://www.24-7pressrelease.com


# # #

Read more Press Releases from FL Web Advantage:


Contact Information:
FL Web Advantage

E-Mail: Email us Here
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7PressRelease. We are unable to assist you with any information regarding this release. 24-7PressRelease disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.